Atomoxetine Hydrochloride FDA approval date

The FDA approved Atomoxetine Hydrochloride on 26 Nov 2002.

FDA approval date
26 Nov 2002

Drug identity checked against registry records

Included trials

TrialSponsorPhaseStatusPrimary completion
Parallel Arm Trial of AD109 and AD504 In Patients With OSANCT05071612ApnimedPhase 2Completed2022-07-20Actual

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2002-11-26DayAtomoxetine HydrochlorideFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA021411", "applicant_as_listed_by_fda": "LILLY", "brand_names": ["STRATTERA"], "active_ingredients": ["ATOMOXETINE HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20021126", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026